Marcus Farbstein Rph

Marcus Farbstein, RPh, MBA has extensive experience in market access and government programs within the pharmaceutical industry. Marcus currently serves as the Director of Market Access at Day One Biopharmaceuticals. Prior to this, Marcus ran their own consulting firm, Marcus Farbstein Consulting, where they provided market access support to biotech companies and managed product launches. Marcus also held leadership positions at Sesen Bio, Iovance Biotherapeutics, Inc., Medivation (acquired by Pfizer), and Genentech, where they focused on pricing, contracting, government affairs, and public policy. Throughout their career, Marcus has demonstrated expertise in navigating the public and private payer markets, establishing pricing strategies, and ensuring compliance with government regulations.

Marcus Farbstein, RPh, MBA received their Bachelor of Science degree in Pharmacy from the University of the Sciences in Philadelphia, where they studied from 1978 to 1983. Marcus then pursued their Master of Business Administration (MBA) in International Finance at Drexel University's LeBow College of Business from 1983 to 1984.